Ortin Global
ORTINGLOBENSE

Ortin Global

₹16.24-0.37 (2.23%)1D
1D
1W
1M
3M
6M
1Y
3Y
5Y
All
Create Stock SIPAutomate your investments in this
Overview
Technicals
News
Events

Performance

Today’s low
15.78
Today’s high
17.39
52 week low
10.66
52 week high
21.30
Open price
16.22
Previous close
16.61
Live volume
49,278
Lower circuit
15.43
Upper circuit
17.05

Fundamentals

Market Cap
₹14Cr
ROE
-59.85%
P/E Ratio(TTM)
--
EPS(TTM)
-0.91
P/B Ratio
11.27
Dividend Yield
0.00%
Industry P/E
46.84
Book Value
1.53
Debt to Equity
0.81
Face Value
10

Financial performance

Quarterly
Yearly
All Financials
MAR '26
Revenue (Cr)
₹0.30
+2,900.00%
Profit (Cr)
-₹0.01
+80.00%
-2-1012
Mar '25
Jun '25
Sep '25
Dec '25
Mar '26
Revenue growthValue
1Y (TTM)+233%
3Y CAGR-64%
Profit growthValue
1Y (TTM)+1,500%
3Y CAGR-22%

About

Ortin Global Limited, formerly Ortin Laboratories, is a public company engaged in trading pharmaceuticals, drugs, various medicines, and is also involved in real estate. Its philosophy on Corporate Governance is built on principles of Concern, Commitment, Ethics, Excellence and Learning in its relationships with stakeholders, clients, and the community. The company has strategically shifted from manufacturing to trading products after its manufacturing license was cancelled due to non-compliance with regulatory provisions. Consequently, the company sold its entire Property, Plant & Equipment, except for vehicles, and utilized the proceeds to repay its external debts. The company is currently in an expansion mode which requires significant upfront investment, leading to minimal profits in the initial years. Management is committed to building business operations within budget and believes the company’s financial position will improve considerably in the coming years.;
CEO/MD
Murali Krishna Murthy Sanka
Founded in
1986
NSE symbol
ORTINGLOBE

Shareholding Pattern

Mar '26
Dec '25
Sep '25
Jun '25
Mar '25
Retail And Others
92.24%
Foreign Institutions
6.53%
Promoters
1.23%

Similar stocks

StockMkt price (1D)52 week performanceMarket capP/E ratioP/B ratio
₹8,310.50
+68.50 (0.83%)
L
    H
    20,589.75109.823.59
    ₹833.80
    +8.10 (0.98%)
    L
      H
      20,481.6534.434.03
      PfizerPFIZER
      ₹4,568.60
      +129.20 (2.91%)
      L
        H
        20,301.4728.14.83
        ₹1,431.10
        -17.60 (1.21%)
        L
          H
          20,055.7830.975.14
          2026
          30
          May
          Quarterly & Annual Result
          Release date
          14
          Feb
          Quarterly Result
          Release date
          2025
          14
          Nov
          Quarterly Result
          Release date
          14
          Aug
          Quarterly Result
          Release date
          Events calendar
          View upcoming events in other stocks